I'M AN ORIGINAL CATCHPHRASE
I’m a paragraph. Double click here or click Edit Text to add some text of your own or to change the font. This is the place for you to tell your site visitors a little bit about you and your services.
J. Roberto Trujillo, M.D., Sc.D.
J. Roberto Trujillo is a Mexican American physician, scientist, inventor, entrepreneur, and the Founder, Chairman, and CEO of NeuroCytonix, Inc., a cutting-edge translation research technology biotech focused on tissue engineering and regeneration for the cure of neurodegenerative diseases such as stroke and cerebral Palsy.
Dr. Trujillo's pioneering ideas of regeneration medicine are transforming the status quo of healthcare. He built an FDA-compliant Good Clinical Practice research center. He trained and directed an outstanding clinical research team for FDA trials. In addition, he raised several million dollars as seed money for his mission of “Curing the Incurable”
Dr. Trujillo’s exceptional medical and research career began at the University Autonomous of Mexico State, where he graduated medical school with Suma Cum Laude Honors. As a medical student he won a training award, Mexico State Award for a Neurology Clerkship, at the Houston Neurological Center, Methodist Hospital, Houston, Texas.
Following an internship in medicine at Baylor College of Medicine, he completed a two-year Clinical Neurological and Neurosurgical Fellowship at Texas Medical Center. Dr. Trujillo’s MD thesis was on the use of immunosuppression therapy for Multiple Sclerosis patients at the Neurosensory Center of the Methodist Hospital.
After receiving a Training Award from the National Institutes of Health (NIH, USA), Dr. Trujillo obtained his Doctor of Science degree in Neurosciences and Molecular Virology at Harvard University under the direction of Lasker Prize winner Dr. Max Essex. He was the first doctoral student at Harvard University to combine the studies of neuroscience and virology and the first Mexican in the history of Harvard to obtain a Doctor of Science degree in Medical Sciences. As a pioneer in the field of Neurovirology at Harvard, Dr. Trujillo founded the Pan-American Society of NeuroVirology.
He has held several faculty positions at Harvard, the National Institute of Neurological Disorders and Stroke at the NIH, and University of Maryland. Since 2010, he founded and raised support for several biotech companies in the biotechnological corridor of the state of Maryland and Latin American markets.
He is the co-inventor of CerCa, a photodynamic therapeutic medical device for the treatment of Human Papilloma Virus (HPV) and the prevention of cervical cancer. This photodynamic procedure is so simple, portable, and affordable that it can be used in a primary care doctor's office or clinic as part of a woman's routine checkup. Dr. Trujillo’s invention has received numerous international awards and is patented in many countries around the world, including USA, Canada, Mexico, China, Japan and Europe.
Dr. Trujillo has published over 50 scientific manuscripts and reviews in neurosciences and molecular virology. His studies of viral molecular mimicry and the brain was recognized as the scientific article of the year by Harvard University and by the American Society of Microbiology. He was the first medical-scientist to identify a non-infectious sugar receptor MR for HIV-1 pathogenesis, an ingenious insight for viral vaccines, which was published in the Proceedings of the National Academy of Sciences.
Dr. Trujillo has received numerous awards, professional titles, and honorary doctoral degrees, including: the National Research NIH Award Training; the Helena Rubinstein Award at Harvard University; the Ruth L Kirschstein National Research Service Award; and the Outstanding Professor of NeuroVirology by the Pan-American Society of Neurology.
He is a member of numerous scientific societies including the American Academy of Neurology, the Biophysical Society, and the American Association for the Advancement of Science. Dr. Trujillo is a member of the Cosmos Club, a distinguished private social club in Science, Literature, and Arts located in Washington, D.C. He was recognized as the 100 Most Influential Professional Mexicans in the USA and in 2013, Dr. Trujillo received the Ohtli Award, the highest honor awarded by the Mexican government to recognize individuals of Mexican heritage.
